基本信息
浏览量:0
职业迁徙
个人简介
Jane as Director of the Translational Research office is responsible for a team of 24 highly experienced industrial translational scientists tasked with establishing the organisational culture, capability and processes necessary to deliver the UCL and BRC’s mission of "Accelerating translation for health and wealth". The TRO supports the development of early stage research from across UCL and its partner hospitals, into projects attractive for translational funding or further development with partners and nurture access to complementary capacity, expertise and skills in translational science. The TRO achieves this through the integrated activities of three specialist groups a Drug Discovery Group (DDG) provides expert advice and practical support for small molecule drug discovery projects across UCL; a Translational Research Group who provide experienced project leaders to guide projects (gene, cell and regenerative medicine therapies, devices, diagnostics, small molecules) through their development; and an Industrial Partnerships Group who initiate and manage relationships with industry.
Jane has extensive experience in developing therapies to clinical benefit gained from >20 years working in large pharma and academia. Her experience has spanned the drug discovery pathway from target validation, lead optimisation, candidate selection through to the clinic and to marketing authorisation.
研究兴趣
论文共 5 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Peter J. Atkinson, Meera Swami, Nicola Ridgway, Matthew C. Roberts,Jane Kinghorn,Thomas T. Warner,James M. Staddon,Andrew K. Takle
Drug discovery todayno. 10 (2023): 103732-103732
Neurosurgery (2014): 525-534
作者统计
#Papers: 5
#Citation: 228
H-Index: 3
G-Index: 3
Sociability: 3
Diversity: 1
Activity: 3
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn